VaBio News

03/27/2024

Shaping Tomorrow’s Innovators: LifeNet Health’s Educational Partnership Ignites Student Passion in Life Science

LifeNet Health, a global leader in regenerative medicine, recently collaborated with AP biology students at Landstown High School to offer hands‐on learning experiences with human tissue and cellular solutions. This initiative is part of the Life Sciences Virginia pilot program, which aims to foster interest in life science careers among students and cultivate a talent

02/19/2024

Artificially capping drug prices will only stifle access, innovation

Alleviating high health care costs remains a top priority for Virginia lawmakers this legislative session. While addressing medication affordability and access concerns should remain a priority for everyone, any policy solution to do so must strike a balance between addressing affordability, preserving patient access to critical treatments and protecting Virginia’s leading life sciences innovation ecosystem.

02/14/2024

Call for Judges for Science Fair and BioGENEius Challenge

Each year, Virginia Bio recruits volunteer judges from the membership to attend the Virginia State Science and Engineering Fair to select the top three winners in the field of biosciences. The time commitment is limited to a pre-event online review of the submissions to select the finalists and then a few hours onsite at the

01/30/2024

Virginia Bio-Connect – The Success of Virginia’s First Statewide Collaborative Life Sciences Initiative

The end of 2023 marked the completion of Virginia’s first statewide life sciences initiative, Virginia Bio-Connect, which started in April 2021. This comprehensive industry cluster strengthening project, supported by Virginia Growth and Opportunity Foundation funding and led by the Virginia Biotechnology Association, engaged thousands of life sciences professionals and hundreds of organizations and companies within

01/03/2024

The proposed DRUG Act will spur innovation in biotech, and reduce costs

As the vibrant biotechnology and life sciences industry in Virginia flourishes, our mission at the Virginia Biotechnology Association remains steadfast: to promote innovation and growth through strengthened advocacy, talent attraction, development and retention while advancing the next generation of leaders. We succeed because Virginia encourages risk-takers to develop new health care and technology treatments. Virginia’s

12/20/2023

Virginia Biotechnology Association Announces the Election of Two New Board Members

The Virginia Bio Membership has elected two new Directors to the Virginia Bio Board. Joining the Board are Maria Clarke, Executive Director, J.P. Morgan Private Bank and Susan Mitchell, CEO of Athari Bio.  The new Directors’ 3-year terms will begin in April 2024. “Two years ago, we decided to expand our Board of Directors to